Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

tais-med.com Blueprint · Rev.39

Sheet A · Product board

aod9604 peptide aod9604 what is it AOD-9604 Research | COA Verified Strength:50 mg (60 Tablets) vitamin B12 5-Amino-1MQ 99% Research Peptide

Unit price

USD24.50

USD61.50

Pay in 4 interest-free payments of $6.12 Learn more

Field rating

4.4

Verified studio score · Spec revision current

Fit · Size

aod9604 peptide aod9604 what is it

aod9604 peptide aod9604 what is it AOD-9604 Research | COA Verified Strength:50 mg (60 Tablets) vitamin B12 5-Amino-1MQ 99% Research Peptide

SKU: 98673903630

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 20 - Oct 25

Description

aod9604 peptide aod9604 what is it AOD-9604 Research | COA Verified Strength:50 mg (60 Tablets) vitamin B12 5-Amino-1MQ 99% Research Peptide

5-Amino-1MQ 99% Research Peptide | Redline Bio

2021. NNMT inhibition reduces obesity and diabetes risk

vitamin B12

Strength:50 mg (60 Tablets)

Figure 3)

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

FDA moves BPC-157 to Category 1 by…? Predictions & Odds 2026

FDA moves BPC-157 to Category 1 by…? Predictions & Odds 2026

US$ 21.90

4.8 (29 reviews)

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW⬇️

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW⬇️

US$ 26.35

4.3 (30 reviews)

Is BPC-157 Banned? Oral vs. Injectable Forms Explained

Is BPC-157 Banned? Oral vs. Injectable Forms Explained

US$ 29.26

4.4 (15 reviews)

The peptide market outpaced regulators. Last week, an FDA advisory committee voted to allow pharmacies to compound six peptides, potentially opening a legal pathway for broader distribution. ✓ KPV ✓ Semax ✓

The peptide market outpaced regulators. Last week, an FDA advisory committee voted to allow pharmacies to compound six peptides, potentially opening a legal pathway for broader distribution. ✓ KPV ✓ Semax ✓

US$ 28.28

5.0 (14 reviews)

BIG NEWS FOR BPC 157 Today, the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding BPC 157 to the list of substances that may be eligible for pharmacy

BIG NEWS FOR BPC 157 Today, the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding BPC 157 to the list of substances that may be eligible for pharmacy

US$ 26.65

4.3 (11 reviews)

BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded

BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded

US$ 21.74

5.0 (10 reviews)

BPC 157 Banned: Key Facts on the Latest FDA Decision

BPC 157 Banned: Key Facts on the Latest FDA Decision

US$ 21.72

4.4 (20 reviews)

The FDA panel just voted to recommend BPC-157 and KPV for legal compounding. A first step toward regulated access — not final approval, but the clearest signal yet these peptides are moving

The FDA panel just voted to recommend BPC-157 and KPV for legal compounding. A first step toward regulated access — not final approval, but the clearest signal yet these peptides are moving

US$ 26.83

4.3 (20 reviews)

BPC-157 FDA Approval Status: Is It Approved for Human Use?

BPC-157 FDA Approval Status: Is It Approved for Human Use?

US$ 27.57

4.7 (22 reviews)

BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

US$ 25.20

4.3 (19 reviews)

Peptides, explained: Answers to your top questions

Peptides, explained: Answers to your top questions

US$ 29.63

5.0 (11 reviews)

BPC-157 FDA Approval Status 2026: Clinical Trials

BPC-157 FDA Approval Status 2026: Clinical Trials

US$ 24.21

4.1 (26 reviews)

bpc-157 fda warning unapproved peptide safety to review 7 popular peptides touted for weight loss, healing and longevity On Peptides, FDA Staff Scientists –

bpc-157 fda warning unapproved peptide safety to review 7 popular peptides touted for weight loss, healing and longevity On Peptides, FDA Staff Scientists –

US$ 27.66

4.0 (13 reviews)

fda warning letters bpc-157 FDA's Overreach on Compounded Peptides What to know: the 4

fda warning letters bpc-157 FDA's Overreach on Compounded Peptides What to know: the 4

US$ 23.24

4.0 (24 reviews)

FDA panel recommends loosening regulations for some peptides amid surge in interest

FDA panel recommends loosening regulations for some peptides amid surge in interest

US$ 28.75

4.2 (13 reviews)

FDA Sends Warning Letters to More Than 50 GLP-1 Compounders and Manufacturers

FDA Sends Warning Letters to More Than 50 GLP-1 Compounders and Manufacturers

US$ 29.61

4.5 (5 reviews)

FDA regulators, customs officers, and physicians around the world are continuing to raise alarms about unsafe and unregulated weight-loss and peptide products. An FDA warning letter to ProRx states the company continued

FDA regulators, customs officers, and physicians around the world are continuing to raise alarms about unsafe and unregulated weight-loss and peptide products. An FDA warning letter to ProRx states the company continued

US$ 21.94

4.3 (29 reviews)

why isnt bpc 157 fda approved warning letter unapproved peptide Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr Survey: Half of Peptide-Users An FDA advisory panel voted –

why isnt bpc 157 fda approved warning letter unapproved peptide Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr Survey: Half of Peptide-Users An FDA advisory panel voted –

US$ 29.79

4.6 (27 reviews)

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

US$ 22.62

4.3 (15 reviews)

Regulatory | Topic

Regulatory | Topic

US$ 22.91

4.0 (24 reviews)